Family Dollar Initiates Voluntary Recall of Colgate Products

September 19, 2022 by TWN Staff
Family Dollar Initiates Voluntary Recall of Colgate Products
(Family Dollar photo)

CHARLOTTE, N.C. — Family Dollar is initiating a voluntary product recall of Colgate mouthwash and toothpaste that were shipped and stored in multiple states outside of the products’ labeled temperature requirements.

All of the products are subject to Food and Drug Administration regulation and were shipped and stored at Family Dollar locations between May 1 and June 21, 2022.

The affected states are Arizona, California, Georgia, Indiana, Idaho, Montana, New Mexico, Nevada, Oregon, Texas and Utah.

Family Dollar said as of last Friday it was not aware of any consumer complaints or reports of illness related to this recall.


Products covered by this retail level recall include:


  • 998277 COLGATE OPTIC WHITE STAIN PREVENTION TOOTHPASTE 2.1OZ.
  • 998909 COLGATE OPTIC WHITE CHARCOAL TOOTHPASTE 4.2OZ.
  • 999043 COLGATE OPTIC WHITE MOUTHWASH 16 FL OZ.
  • 999088 COLGATE OPTIC WHITE HIGH IMPACT TOOTHPASTE 3OZ.
  • 999749 COLGATE OPTIC WHITE TOOTHPASTE ICY FRESH 3.2OZ.
  • 999750 COLGATE OPTIC WHITE STAIN FIGHTER TOOTHPASTE CLEAN MNT 4.2OZ.

Family Dollar has notified its affected stores asking them to check their stock immediately and to quarantine and discontinue the sale of any affected product. Customers that may have bought affected products may return them to the Family Dollar store where they were purchased without receipt.

Customers with questions regarding this recall may contact Family Dollar Customer Service at 1-844-636-7687 between 9 a.m. and 5 p.m. Eastern time. 

Customers are also advised to contact their physician or health care provider if they have experienced any problems that may be related to using these products.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.


Complete and submit the report online.

Regular mail or fax: Download the form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

A+
a-

In The News

Health

Voting

Health

October 5, 2022
by Dan McCue
Senators Laud DOD for Imposing Anti-PFAS Procurement Rules

WASHINGTON — The lead Senate sponsors of the PFAS Free Military Purchasing Act this week lauded the Department of Defense’s... Read More

WASHINGTON — The lead Senate sponsors of the PFAS Free Military Purchasing Act this week lauded the Department of Defense’s recent decision to make its own stand against the proliferation of so-called “forever chemicals.” Late last month, the Defense Department issued a Defense Federal Acquisition Regulation... Read More

October 5, 2022
by TWN Staff
Your Medications May Be Hurting Your Teeth

WASHINGTON — According to the Centers for Disease Control and Prevention, nearly seven in 10 adults between the ages of... Read More

WASHINGTON — According to the Centers for Disease Control and Prevention, nearly seven in 10 adults between the ages of 40 and 79 used at least one prescription drug in the past 30 days in the United States, and approximately one in five used at least... Read More

October 5, 2022
by TWN Staff
NIH Awards Over $200 Million to Support Biomedical Research

WASHINGTON — The National Institutes of Health has awarded 103 new research grants, totaling some $285 million, to support highly... Read More

WASHINGTON — The National Institutes of Health has awarded 103 new research grants, totaling some $285 million, to support highly innovative scientists who propose visionary and broadly impactful meritorious behavioral and biomedical research projects. The 2022 NIH Director’s Awards are bestowed through the institute’s High-Risk, High-Reward... Read More

October 5, 2022
by TWN Staff
Study Finds Viagra and Cialis Do Not Reduce Alzheimer’s, Dementia Risk

WASHINGTON — Despite the results of a previous study, sildenafil (Viagra) and tadalafil (Cialis) may not be suitable candidates for... Read More

WASHINGTON — Despite the results of a previous study, sildenafil (Viagra) and tadalafil (Cialis) may not be suitable candidates for treating dementia, according to the National Institutes of Health. The institute recently delved into the situation with its Drug Repurposing for Effective Alzheimer's Medicines study. In... Read More

October 5, 2022
by TWN Staff
US Sees Increase in Respiratory Infections That Can Cause Paralysis in Children

ATLANTA — Doctors should be on the lookout for a possible increase in enterovirus D68, a respiratory infection that may... Read More

ATLANTA — Doctors should be on the lookout for a possible increase in enterovirus D68, a respiratory infection that may be linked to more cases of the rare, paralyzing condition acute flaccid myelitis, the Centers for Disease Control and Prevention said last week. The CDC has... Read More

October 5, 2022
by Dan McCue
Study Could Change Design of Cochlear Implants

PORTLAND, Ore. — The cochlea in the inner ear detects low-frequency sound in a manner very different than previously known,... Read More

PORTLAND, Ore. — The cochlea in the inner ear detects low-frequency sound in a manner very different than previously known, a discovery that may make it possible to design better cochlear implants for people with hearing impairments. The finding is the result of research from scientists... Read More

News From The Well
scroll top